Maprotiline
Based on 4 publication(s) in Google Scholar
Maprotiline is a highly selective noradrenergic reuptake inhibitor that has strong antidepressant, antitumor and neuropathic pain-relieving effects. Maprotiline induces cancer cell apoptosis by targeting the ERK signaling pathway and CRABP1.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 10262-69-8
- Formule: C20H23N
- Masse moléculaire:277.40
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Publications Citing Use of MedChemExpress (MCE) Maprotiline
More
Activité biologique
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| DG-75 | EC50 |
37.5 μM
Compound: 1
|
Antiproliferative activity against human DG75 cells after 72 hrs by Alamar blue assay
Antiproliferative activity against human DG75 cells after 72 hrs by Alamar blue assay
|
[PMID: 24333581] |
| Ventricular myocyte | IC50 |
31 μM
Compound: Maprotiline
|
Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes
Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes
|
[PMID: 22761000] |
Maprotiline (0-20 μM, 0-72 h) inhibits the growth of Huh7 and HepG2 cells and induces cell apoptosis[1].
Maprotiline (0-20 μM, 0-72 h) inhibits the metastasis of liver cancer cells[1].
Maprotiline (0-20 μM, 72 h) affects the ERK pathway and inhibits the phosphorylation of SREBP2 in HepG2 and Huh7 cells[1].
Maprotiline targets CRABP1 and regulates cholesterol biosynthesis in HCC cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:The human HCC cell lines Huh7 and HepG2
-
Concentration:0, 10, 20 μM
-
Incubation Time:24 hours
-
Result:Restrained HCC cells migration with inhibition of epithelial-mesenchymal transition (EMT).
-
Cell Line:The human HCC cell lines Huh7 and HepG2
-
Concentration:0, 10, 20 μM
-
Incubation Time:0, 24, 48, 72, 96, 120 hours
-
Result:Triggered cell apoptosis and inhibited the cell viability of Huh7 and HepG2 cells in a dose- and time-dependent manner.
-
Cell Line:The human HCC cell lines Huh7 and HepG2
-
Concentration:0, 10, 20 μM
-
Incubation Time:72 hours
-
Result:Inhibited cholesterol biosynthesis in HCC Cells.
Maprotiline (3-30 mg/kg, intravenous injection, single dose) combined with the synthetic cannabinoid WIN 55,212-2 effectively reduces neuropathic pain in mice[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Nude mice (BALB/C nu/nu, 4–6 weeks old, female)[1]
-
Dosage:20, 40 mg/kg
-
Administration:Intraperitoneal injection (i.p.); twice a week; 3 weeks
-
Result:Decreased the cholesterol levels in serum and tumors and suppressed the growth of Huh7-derived tumor xenografts without obvious toxic effect.
-
Animal Model:Male Balb-c mice (25–30 g)[2]
-
Dosage:3, 10, 30 mg/kg; single dose
-
Administration:Intravenous injection (i.v.)
-
Result:Attenuated pain-related behaviours in neuropathic mice.
Chemical Information
-
CAS No. 10262-69-8
-
Masse moléculaire 277.40
-
Formule C20H23N
-
SMILES
CNCCCC12C3=C(C=CC=C3)C(CC2)C4=CC=CC=C14
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (4)
-
Journal Impact Factor
-
Most Recent
-
Autophagy
2025 May;21(5):934-956. PMID: 39663580 -
Adv Sci (Weinh)
Network Medicine-Based Strategy Identifies Maprotiline as a Repurposable Drug by Inhibiting PD-L1 Expression via Targeting SPOP in Cancer. [Abstract]2025 Jan;12(1):e2410285. PMID: 39499771 -
Cell Rep Methods
RECOVER identifies synergistic drug combinations in vitro through sequential model optimization. [Abstract]2023 Oct 23;3(10):100599. PMID: 37797618 -
PLoS Negl Trop Dis
Identification of anti-flaviviral drugs with mosquitocidal and anti-Zika virus activity in Aedes aegypti. [Abstract]2019 Aug 20;13(8):e0007681. PMID: 31430351
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Maprotiline Related Classifications
HY-B0444A Related Classifications
Powered by Bioz